Amanote Research
Register
Sign In
Selective Inhibition of BCL2 Shows Antitumor Effects in Lung Cancer
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2015-102
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
June 4, 2015
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
FGFR1 Cooperates With EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeting CD47 and Autophagy Elicited Enhanced Antitumor Effects in Non–Small Cell Lung Cancer
Cancer immunology research
Cancer Research
Immunology
Cationic Liposome-Mediated Nitric Oxide Synthase Gene Therapy Enhances the Antitumor Effects of Cisplatin in Lung Cancer
International Journal of Molecular Medicine
Medicine
Genetics
Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) Through Multi-Kinase Inhibition
Clinical Cancer Research
Cancer Research
Oncology
Antitumor Effect of Combined NAMPT and CD73 Inhibition in an Ovarian Cancer Model
Oncotarget
Oncology
Novel Role of Granulocyte-Macrophage Colony-Stimulating Factor: Antitumor Effects Through Inhibition of Epithelial-To-Mesenchymal Transition in Esophageal Cancer
OncoTargets and Therapy
Oncology
Pharmacology
Antitumor Effects of L-Blp25 Antigen-Specific Tumor Immunotherapy in a Novel Human MUC1 Transgenic Lung Cancer Mouse Model
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
